-
Direct Mouse Genotyping Kit for Faster Screening
2026-08-13
Accelerate PCR amplification from mouse tissue by replacing routine DNA purification with optimized lysis, balancing, and direct template addition. The workflow is especially useful for mouse genetic screening, colony management, and high-throughput genotyping when the endpoint is a defined PCR band rather than purified genomic DNA.
-
Caspase-3–NDUFS1 Axis in Trichothecene Hepatotoxicity
2026-08-13
This preprint identifies caspase-3-mediated cleavage of the mitochondrial complex I subunit NDUFS1 as a mechanistic amplifier of ROS accumulation after exposure to deoxynivalenol and T-2 toxin. By connecting mitochondrial electron transport injury with ERO1α-dependent endoplasmic reticulum oxidative stress, the study provides a framework for interpreting trichothecene-induced liver damage and designing more discriminating mitochondrial assays.
-
Latrunculin A for Actin Dynamics Workflows
2026-08-12
Latrunculin A provides a rapid, reversible way to connect actin remodeling with substrate stiffness, growth-cone behavior, morphology, and motility. This workflow-oriented guide shows how to use controlled actin cytoskeleton disruption without confusing a downstream perturbation with direct evidence for Piezo1 signaling.
-
Phebestin Targets Plasmodium Aminopeptidases
2026-08-12
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial candidate active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its combination of stage-wide parasite inhibition, persistent post-washout effects, predicted binding to two parasite aminopeptidases, and activity in murine malaria models provides a useful framework for evaluating peptidase-directed antimalarial compounds.
-
Trichostatin A (TSA) Cancer Research Workflows
2026-08-11
Trichostatin A (TSA) turns histone acetylation into a controllable experimental variable for cancer, differentiation, and senescence studies. This guide pairs dose–time design with orthogonal telomerase, mitochondrial, cell-cycle, and chromatin readouts to distinguish HDAC-dependent effects from broader cytotoxicity.
-
Resazurin Cell Viability Assay Kit for Bone Research
2026-08-10
Use a redox-based cell viability assay to distinguish treatment-related cytotoxicity from changes in osteoblast function during Wnt-pathway research. The Resazurin Cell Viability Assay Kit supports sensitive fluorescence, colorimetric, and high-throughput workflows without washing, making it useful for LGK974 dose-finding and assay quality control.
-
Dimetridazole Workflows for Antimicrobial Research
2026-08-09
Dimetridazole supports more than routine antimicrobial screening: it can connect anaerobic culture, quorum-sensing, biofilm, combination, infection-model, and residue-detection workflows. This guide translates its research profile into practical assay design, optimization steps, and electrochemical sensing choices.
-
Resazurin Cell Viability Assay Kit in Oncology
2026-08-08
The Resazurin Cell Viability Assay Kit converts viable-cell redox activity into sensitive fluorescence or colorimetric data without washing or cell lysis. Its flexible workflow supports oncology dose–response studies, high-throughput screening, and cross-validation of apoptosis mechanisms across diverse cell models.
-
TCAIM Controls OGDH and Mitochondrial Metabolism
2026-08-07
Wang et al. identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The work establishes mitochondrial proteostasis as a post-translational regulator of OGDH complex activity, carbohydrate catabolism, and broader metabolic state.
-
Bufalin-CRISPR Nanomedicine Induces Pyroptosis for CRC Immun
2026-08-07
This study introduces a calcium lactate nanoparticle system co-delivering bufalin and CRISPR/Cas9 RNPs targeting CD47 for synergistic colorectal cancer immunotherapy. The innovation lies in combining pyroptosis induction, macrophage reprogramming, and immune checkpoint editing to enhance antitumor responses and overcome resistance.
-
Ademetionine (SAM) in Translational Research: Mechanisms and
2026-08-06
This thought-leadership article explores the pivotal mechanistic and translational roles of S-Adenosylmethionine (Ademetionine, SAM) in modern biomedical research. Integrating recent evidence on methionine metabolism disruption, autophagy regulation, and clinical applications, it provides actionable strategic guidance for translational scientists. The article contextualizes APExBIO’s high-purity SAM (SKU B3513) as a cornerstone reagent, examines competitive and protocol landscapes, and outlines a forward-looking vision for SAM-based innovation.
-
miR-18a/ALOXE3 Axis Drives Ferroptosis Resistance in GBM
2026-08-06
Yang et al. reveal that miR-18a promotes glioblastoma by downregulating ALOXE3, reducing ferroptosis and enhancing tumor cell migration through Gs protein-coupled signaling. This study uncovers a novel regulatory mechanism in glioblastoma lipid metabolism, highlighting a promising target for future cancer biology research.
-
Transmission Dynamics of Carbapenemase Genes in CREC, Guangd
2026-08-05
This study provides the first comprehensive molecular and epidemiological characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) isolates from multiple teaching hospitals in Guangdong during the COVID-19 pandemic. The findings highlight the dominance of plasmid-borne blaNDM-1, high multidrug resistance, and efficient gene transfer, offering vital insights for antimicrobial strategy development.
-
Resazurin Cell Viability Assay Kit: Precision in Advanced Ce
2026-08-05
Discover how the Resazurin Cell Viability Assay Kit offers ultra-sensitive, non-toxic, high-throughput cell proliferation analysis. This article uniquely explores the assay's mechanistic depth and its pivotal role in translating basic research into advanced therapeutic discovery.
-
Cathepsin B Inhibition: Mechanistic Leverage for Translation
2026-08-04
This thought-leadership article unpacks the mechanistic and translational value of the cathepsin B inhibitor CA-074, with strategic guidance for researchers targeting necroptosis, cancer metastasis, and neurodegeneration. Integrating new mechanistic insights from MLKL-driven lysosomal membrane permeabilization, it offers a critical perspective on the evolving competitive landscape and actionable workflow advice.